Contrast agent

1 marketed 2 in Phase 3 1 in Phase 2

This page covers all Contrast agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.

Marketed (1)

Contrast agent · University Hospital Muenster · Diagnostic Imaging
Contrast agents enhance the visibility of internal body structures during medical imaging by altering the magnetic properties or radiodensity of tissues.

Phase 3 pipeline (2)

Sonazoid™ · GE Healthcare · Radiology
Sonazoid is a liver-specific contrast agent that enhances the visibility of liver lesions during MRI.
Vasovist (BAY86-5283, MS-325) · Bayer · Imaging
Vasovist is a gadolinium-based contrast agent that works by enhancing the visibility of blood vessels in magnetic resonance imaging (MRI) scans.

Phase 2 pipeline (1)

GBCAs · Bayer · Imaging
Gadolinium-based contrast agents work by providing a contrast between the magnetic properties of tissues and the surrounding environment, allowing for better visualization of internal structures during MRI scans.